This study investigates the use of an investigational molecular probe in diagnosing tumors. The probe is labeled with radioactive isotopes and targets a specific protein associated with tumors.
The study evaluates the safety and effectiveness of this probe in identifying tumors. This study investigates providing new insights into tumor diagnosis using advanced imaging techniques.
- Who can participate: Adults aged 18 to 75 years with suspected tumors identified through imaging methods like CT or MRI are eligible. Participants should have specific types of cancer, such as lung, thyroid, or pancreatic cancer, and meet certain health criteria.
- Study details: Participants will undergo imaging using the investigational probe.
How understandable was the trial content above?
Hard to understand
Easy to understand